PVEK Corneal Implant For Treatment of Corneal Edema

Recruiting Phase 1 Interventional Study
Corneal Edema Fuchs' Endothelial Dystrophy Pseudophakic Bullous Keratopathy Corneal Endothelial Dysfunction
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
15 (estimated)
Sponsor
Precise Bio · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if PVEK, a corneal implant , is safe and well tolerated for people with corneal swelling caused by Fuchs' endothelial dystrophy or pseudophakic bullous keratopathy who need endothelial keratoplasty. The main questions it aims to answer are: What side effects may happen after the PVEK implant? How many participants can complete the first 6 months after…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: age 18/50 years or older Corneal edema requiring endothelial keratoplasty due to Fuchs' endothelial dystrophy and/or pseudophakic bullous keratopathy Pseudophakic study eye Best corrected visual acuity (BCVA) in the study eye between 6/379 (1.8 logMAR) and 6/12 (0.3 logMAR) …
Contacts

Amos Eitan

+972 54 7854387

amos.eitan@precise-bio.com

CONTACT

Lior Rosenberg Belmaker

+972 52 385 8875

lior.rb@precise-bio.com

CONTACT